IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nephrogenex Inc

Q2 2016 vs Q3 2016

Comparing institutional holders between quarters

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Vantage Investment Advisors, LLC
UNCHANGED
Shares3,700 from 3,700
Change0 (0%)
Value$0 ($0)
Filed 2016-11-09
Status
Vantage Investment Advisors, LLC
UNCHANGED3,7003,70000%$0$0$02016-11-09
Showing 1 of 1 institutions